Fondazione Policlinico Universitario Agostino Gemelli | Dermatology Department

Research site
8 Largo Agostino Gemelli, Rome, Rome, Italy
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

The primary objective of the study is to estimate the antitumor efficacy of nanrilkefusp alfa in combination with pembrolizumab in selected tumors.

Active, not recruiting
Cutaneous Squamous Cell Carcinoma
Castration-resistant Prostate Cancer
Drug: Pembrolizumab
Drug: Nanrilkefusp Alfa

The primary objective of the study is to demonstrate superior efficacy of Xevinapant (Debio 1143) vs placebo when added to chemoradiotherapy (CRT) in...

Active, not recruiting
Squamous Cell Carcinoma of the Head and Neck
Drug: Placebo
Drug: Xevinapant (Debio 1143)

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-3248, an oral small molecul...

Active, not recruiting
Solid Tumor, Adult
Urothelial Carcinoma
Drug: KIN-3248

Trial conditions

Carcinoma (2 trials)
Colorectal Cancer (2 trials)
Pancreatic Cancer (2 trials)
Respiratory Insufficiency (2 trials)
Squamous Cell Carcinoma (2 trials)
Anterior Wall Myocardial... (1 trial)
Cholangiocarcinoma (1 trial)
Cholangitis (1 trial)
Cholecystitis (1 trial)
Cholecystolithiasis (1 trial)

And 16 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems